insurance no longer covering glp 1 Major changes are coming to GLP-1 drugs for weight loss. Here's how that could affect patients GLP-1 Insurance - Why Employers
Description
Fernandez AM, Torres-Alemn I
138 To date, there are limited data on clinically significant metabolic enzyme- or transporter-mediated DDIs involving GLP-1 RAs and a dual GLP-1/GIP RA
IDF DIABETES ATLAS
When looking at specific mental health conditions, semaglutide use was linked to significantly lower risks of worsening depression, anxiety, and substance use disorders
Weight stigma remains a powerful force, with some users facing judgment for using medication rather than willpower to manage weight
doi: 10.1016/j.xcrm.2021.100387 [DOI] [PMC free article] [PubMed] [Google Scholar] 104
